Insider · CIK 0001242616

THOMAS FRANK E

Reports to the SEC for 6 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001242616

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	85,000
2026-06-23	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2026-05-19	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+55.2K sh	—	—	55,150
2026-02-27	LRMRLarimar Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$5.00	+$25K	7,000
2025-06-12	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+20K sh	—	—	75,000
2025-05-13	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2024-05-29	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+20K sh	—	—	55,000
2024-05-29	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2024-02-14	LRMRLarimar Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	$11.00	+$22K	2,000
2024-01-24	Orchard Therapeutics plcD Disposition to Issuer	See Remarks	DDisposition to Issuer	−92.1K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−100K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−200K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−150K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−310K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−27.7K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−335K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−458K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−75K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−406K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−179K sh	—	—	0
2023-10-05	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+20K sh	—	—	35,000
2023-05-09	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,300 sh	—	—	8,300
2023-03-10	Orchard Therapeutics plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+20K sh	$0.46	+$9,182	92,081
2023-03-10	Orchard Therapeutics plcStock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−20K sh	—	—	335,000
2023-03-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+406K sh	—	—	405,600
2023-03-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+179K sh	—	—	179,400
2023-02-09	Orchard Therapeutics plcM Exercise/Conversion	See Remarks	MExercise/Conversion	+20K sh	$0.46	+$9,182	72,081
2023-02-09	Orchard Therapeutics plcStock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−20K sh	—	—	355,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−426K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+426K sh	—	—	426,185
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−184K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+184K sh	—	—	184,229
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−100K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+100K sh	—	—	100,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−200K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+200K sh	—	—	200,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−150K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+150K sh	—	—	150,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−310K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+310K sh	—	—	310,000
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−27.7K sh	—	—	0
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+27.7K sh	—	—	27,731
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+458K sh	—	—	457,811
2022-10-04	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+75K sh	—	—	75,000
2022-09-15	SPROSpero Therapeutics, Inc.A Award	Director	AAward	+15K sh	—	—	15,000
2022-06-01	Orchard Therapeutics plcStock Option (Right to Buy)A Award	See Remarks	AAward	+375K sh	—	—	375,000
2022-05-10	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,300 sh	—	—	8,300
2022-04-01	Orchard Therapeutics plcP Purchase	See Remarks	PPurchase	+10K sh	$0.75	+$7,474	52,081
2022-01-05	SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,214 sh	$9.03	+$20K	2,214
2021-08-17	SPROSpero Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500

Recent filings

Accepted (ET)
Jun 254
THOMAS FRANK E0001193125-26-283209
SEC(opens sec.gov)
May 204
THOMAS FRANK E0001193125-26-232657
SEC(opens sec.gov)
Mar 24
THOMAS FRANK E0001193125-26-085514
SEC(opens sec.gov)
Jun 164
THOMAS FRANK E0000950170-25-087009
SEC(opens sec.gov)
May 144
THOMAS FRANK E0001062993-25-009377
SEC(opens sec.gov)
May 314
THOMAS FRANK E0001062993-24-011572
SEC(opens sec.gov)
May 304
THOMAS FRANK E0000950170-24-066617
SEC(opens sec.gov)
Feb 154
THOMAS FRANK E0001062993-24-003312
SEC(opens sec.gov)
Jan 244
THOMAS FRANK E0000950170-24-007078
SEC(opens sec.gov)

Companies

Address

C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR

CAMBRIDGE, MA, 02139